Equities

Batm Advanced Communications Ltd

BVC:LSE

Batm Advanced Communications Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)15.08
  • Today's Change0.15 / 1.01%
  • Shares traded225.01k
  • 1 Year change-19.49%
  • Beta1.2633
Data delayed at least 20 minutes, as of Feb 06 2026 16:21 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Batm Advanced Communications Ltd's net income fell 11,452.33% from a loss of 193.00k to a larger loss of 22.30m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 67.19% to 68.64%.
Gross margin32.22%
Net profit margin-6.06%
Operating margin-4.38%
Return on assets-4.44%
Return on equity-6.36%
Return on investment-5.99%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Batm Advanced Communications Ltd fell by 6.44m. Cash Flow from Investing was negative at 1.22m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.65m for operations while cash used for financing totalled 2.61m.
Cash flow per share-0.0044
Price/Cash flow per share--
Book value per share0.1696
Tangible book value per share0.1486
More ▼

Balance sheet in USDView more

Batm Advanced Communications Ltd has a Debt to Total Capital ratio of 8.44%, a higher figure than the previous year's 3.09%.
Current ratio2.28
Quick ratio1.49
Total debt/total equity0.0909
Total debt/total capital0.0844
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -736.67%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-378.32
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.